{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-035596","form_type":"8-K","ticker":"ARDX","cik":"0001437402","company_name":"ARDELYX, INC.","filed_at":"2023-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.078749+00:00","generated_at":"2026-06-09T04:30:07.723272+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ardelyx reports Q3 net income $6.6M; IBSRELA sales $22.3M; raises FY guidance to $76-78M","bullets":["Q3 net income $6.6M ($0.03/share) vs net loss $22.9M in Q3 2022; total revenue $56.4M vs $5.0M.","IBSRELA U.S. net sales $22.3M (22% QoQ growth); FY 2023 guidance raised to $76-78M.","XPHOZAH FDA approved Oct 17, 2023; commercial launch underway, product in channel early Nov.","Cash, cash equivalents & short-term investments $165.1M at Sep 30; ~$218.1M as of Oct 30.","Received $30M milestone from Kyowa Kirin for Japan approval; drew $22.5M from SLR loan amendment."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-035596","json":"https://secwatch.observer/filing/0001628280-23-035596.json","markdown":"https://secwatch.observer/filing/0001628280-23-035596.md","text":"https://secwatch.observer/filing/0001628280-23-035596.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1437402/000162828023035596/0001628280-23-035596-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1437402/000162828023035596/ardx-20231031.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T04:30:07.723272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cdc18e75b4a102d7147aa2882899ece6b80e94eb","claim":"ARDELYX, INC. updated its the third quarter ended September 30, 2023 guidance (reaffirmed).","evidence_excerpt":"On October 31, 2023, Ardelyx, Inc. (the “Company”) announced its financial results for the quarter ended September 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1437402/000162828023035596/0001628280-23-035596-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}